Monoclonal Antibody Treatment
We are offering monoclonal antibody (mAb) therapy at our three hospital locations to treat COVID. This one-time infusion treatment has received emergency use authorization (EUA) from the FDA – U.S. Food and Drug Administration. If you get sick with COVID, it can keep you from getting sicker and going to the hospital.
Therapy Benefits
In clinical trials, monoclonal antibody therapy is the only treatment that has been shown to keep patients out of the hospital. Unlike other available treatments, monoclonal antibodies work best before patients need oxygen. The main benefit of this therapy is keeping people out of the emergency room, out of the hospital and out of the Intensive Care Unit. When we give it within the first few days of sickness, we see the benefits.
By giving this medication, we know that we can keep people in their home – which is really important – and help keep them from getting severely ill.
You might be eligible for monoclonal antibody therapy if:
You tested positive for COVID-19 within the last 4 days;
Your symptoms began in the past 7-10 days, and;
You have health conditions that put you at high risk
Talk to your doctor that provided you with a positive COVID-19 result to see if monoclonal antibody therapy is right for you.
